when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Monoclonal Antibody · news · pharmadog

← back to Monoclonal Antibody

News · Monoclonal Antibody

554 stories

May 7, 26Approaching First-Line Treatment in PD-L1 CPS <1 HER2-Positive GEAonclive

May 7, 26Reigniting Your Curiosity During Fellowshiponclive

May 6, 26Dr McGregor on the DAD-IO Trial of Sacituzumab Govitecan and EV in Metastatic Urothelial Carcinomaonclive

May 6, 26Dr Chari on Frontline Combinations and Transplant Approaches in Multiple Myelomaonclive

May 6, 26Lonza looks to ride ADC wave with upcoming factory, workforce expansionendpoints

May 6, 26Cases and Conversations™: Next-Generation Pathology Advances and Considerations for Precision Care in Non–Small Cell Lung Canceronclive

May 6, 26Dr Herrera on the Significance of the FDA Approval of Nivolumab Plus AVD for Classical Hodgkin Lymphomaonclive

May 6, 26Dr Sznol on Biomarkers of Response in Metastatic Melanomaonclive

May 6, 26Transformational Utah Investment in Artificial Intelligence and Computing to Advance Health and Discoveryonclive

May 6, 26STAT+: Color Health moving deeper into cancer services, complete with virtual ‘tumor boards’stat

May 6, 26Avalo shares spike on skin drug data; BioNTech to cut staffbiopharma dive

May 6, 26ASCO 2026 HR+ and HER2+ Breast Cancer Preview: Read up on the Insights to Know Before You Goonclive

May 6, 26STAT+: Novo Nordisk’s less-bad news on its Wegovy pill boosts earnings and share pricestat

May 6, 26Disease Assessment and Mutational Testing in Progressive CLLonclive

May 6, 26Clinical Scenario Presentation and Treatment Approach for Progressive Diseaseonclive

May 6, 26Dr Pant on the Mechanism of Action of Daraxonrasib in PDAConclive

May 5, 26Dr Cohen on Frontline Chemotherapy Selection in Metastatic Pancreatic Canceronclive

May 5, 26Dr Pant on Managing Toxicities With Daraxonrasib in PDAConclive

May 5, 26STAT+: A new attack on AMA’s billing codesstat

May 5, 26Breast Cancer Experts Preview Abstracts to Watch at the 2026 ESMO Breast Cancer Congressonclive

May 5, 26The Type of Fat—Not the Amount—Fuels Pancreatic Canceronclive

May 5, 26STAT+: Are analysts too quick to gloss over Lilly’s liver case?stat

May 5, 26Dr McGregor on Key End Points of the STRIKE Trial of Tivozanib Plus Pembrolizumab in RCConclive

May 5, 26Dr Kuykendall on the Evolving JAK Inhibitor and Transplant Considerations in Myelofibrosisonclive

May 5, 26New Endometrial Targets Beyond HER2onclive

May 5, 26Coordinating Care in Multiple Myeloma Across Practice Settingsonclive

May 5, 26STAT+: Cytokinetics drug Myqorzo meets twin efficacy goals in study of genetic heart diseasestat

May 5, 26STAT+: Johnson & Johnson advances IBD therapy, despite trial missstat

May 4, 26Researchers urge study of paternal deaths, though a new paper finds fatherhood is protectivestat

May 4, 26STAT+: Pump the brakes on AI, buddy; and deposition deadlockstat

← prevpage 18 of 19next →